SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-196632
Filing Date
2022-07-19
Accepted
2022-07-19 08:21:34
Documents
14
Period of Report
2022-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d381668d8k.htm   iXBRL 8-K 26674
2 EX-99.1 d381668dex991.htm EX-99.1 9894
6 GRAPHIC g381668g0719013049216.jpg GRAPHIC 5718
  Complete submission text file 0001193125-22-196632.txt   171691

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alpn-20220713.xsd EX-101.SCH 2896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alpn-20220713_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alpn-20220713_pre.xml EX-101.PRE 11288
8 EXTRACTED XBRL INSTANCE DOCUMENT d381668d8k_htm.xml XML 3359
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 221090438
SIC: 2834 Pharmaceutical Preparations